Crossmark

Comparison of the safety and efficacy of moderately hypofractionated and conventionally fractionated radiotherapy for localized prostate cancer: evidence from 9074 men in 13 randomized clinical trials

Crossref DOI link: https://doi.org/10.1186/s12885-025-15018-7

Published Online: 2025-10-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Huizhu

Chen, Jiayan

Lyu, Feng

Ma, Mingwei

Qi, Xin

Ren, Xueying

Qin, Shangbin

Li, Xiaomei

Li, Xiaoying

Gu, Xiaobin

Li, Xueying

Li, Hongzhen

Gao, Xianshu
Funding

Funding for this research was provided by:

Beijing Municipal Natural Science Foundation (7244422, L232126)

National Natural Science Foundation of China (82271771)
License Information

Text and Data Mining valid from 2025-10-23

Version of Record valid from 2025-10-23
More Information

Article History

Received: 9 May 2024

Accepted: 9 September 2025

First Online: 23 October 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below